Tilray CEO: Opportunities in medical cannabis are expansive
Tilray’s stock is up on the present time, but serene down 80 p.c from a February excessive. CNBC’s Frank Holland stories on his dialog with Tilray CEO Irwin Simon about…
Tilray’s stock is up on the present time, but serene down 80 p.c from a February excessive. CNBC’s Frank Holland stories on his dialog with Tilray CEO Irwin Simon about…